BRIEF—Microbiome research picks up pace in Denmark

Danish microbiome company Clinical Microbiomics has acquired a local metabolomics provider, MS-Omics, for an undisclosed sum.

The clonal-level microbiome profiling specialist is seeking to add expertise in metabolite profiling to advance its systems biology platform.

Chief executive Anders Grøn said there was “an unmet need in the microbiome field for better solutions to integrate microbiome and metabolome data.”

He added: “This demands a truly interdisciplinary approach – one that is made possible through this acquisition. We’re excited to engage with our network of researchers around the world to bring the new platform and services to work.”

Founded in 2015, Clinical Microbiomics recently announced the finalization of a 10 million euro ($9.74 million) investment from Seventure Partners.